Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Placebo-Controlled Double-Blind Randomized Trial of CNV1014802 in Trigeminal Neuralgia
2010-023963-16Phase 2Completed
- Sponsor
- Convergence Pharmaceuticals
- Start
- Oct 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in trigeminal neuralgia (TN) comparing CNV1014802 with Placebo (2 arms). Primary endpoint: Primary treatment failure endpoint. Started Oct 2011; status: completed.
02
Drugs
vixotrigine
03
Conditions
trigeminal neuralgia (TN)
Beyond the preview
Go deeper on 2010-023963-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-023963-16.